ASX/EPI (ASX/EPI)

Australian Securities Exchange: ASX/EPI · AUD

A$0.27

+0.00 (0.0%)· Recorded snapshot

Market cap	57.4M
Revenue (ttm)	2.1M
Net income (ttm)	-42.7M
EPS (ttm)	-A$0.28
Shares out	216.7M
Volume	59,586

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1M
Net income (ttm): -42.7M
EPS (ttm): -A$0.28
Market cap: 57.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-301.9

P25 -108P50 -50.6P75 1.1

ROIC-52.1

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/EPI indicators

Market & fundamental data

Available fields

146

Groups with data

Currency

AUD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-24
Enterprise value	AUD 41.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2017
Industry	Medical Devices
Is primary listing	Yes
ISIN number	AU0000432239
Last earnings date	2026-08-31
Last refreshed	2026-10-30
Market cap	AUD 57.4M
Next earnings date	2026-11-24
Price	AUD 0.27
Price currency	AUD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-30
Symbol	asx/EPI
Website	https://epiminder.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-106.91%
EV/Sales	19.3x
FCF / EV yield	-105.24%
FCF yield	-75.43%
P/B ratio	0.7x
P/S ratio	26.93x
Price / tangible book value	0.84x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-1,657.27%
Pretax margin	-2,004.36%
ROA	-38.93%
ROCE	-42.64%
ROE	-301.87%
ROIC	-52.15%
SBC / revenue	294.32%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	379.1%
Gross profit growth (Q)	677.63%
Revenue growth	379.1%
Revenue growth (Q)	677.63%
Revenue growth (QoQ)	296.97%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -50,000
Depreciation and amortization	AUD 39,000
EBIT	AUD -35.3M
EBITDA	AUD -35.3M
EPS	AUD -0.28
FCF per share	AUD -0.20
Financing cash flow	AUD 110M
Free cash flow	AUD -43.3M
Free cash flow minus SBC	AUD -49.6M
Gross profit	AUD 2.1M
Investing cash flow	AUD -50,000
Net borrowing	AUD 502,000
Net cash flow	AUD 66.9M
Net income	AUD -42.7M
Operating cash flow minus SBC	AUD -49.5M
Operating income	AUD -35.3M
Revenue	AUD 2.1M
Stock-based compensation	AUD 6.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.47
Book value per share	AUD 0.38
Debt / equity	0
Interest coverage	-28.96
Long-term assets	AUD 13.2M
Long-term liabilities	AUD 1.2M
Net cash (debt)	AUD 16.3M
Net cash / market cap	28.32%
Net debt / equity	-0.2
Piotroski F-Score	2
Property, plant and equipment	AUD 84,000
Shareholders' equity	AUD 81.7M
Tangible book value	AUD 68.5M
Tangible book value per share	AUD 0.32
Total assets	AUD 90.8M
Total cash	AUD 16.3M
Total debt	AUD 0
Total liabilities	AUD 9.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.04
Current assets	AUD 77.6M
Current liabilities	AUD 8M
Current ratio	9.74
Net working capital	AUD 53.4M
Quick ratio	2.18
Working capital	AUD 69.6M
Working capital turnover	0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-169.87%
Shareholder yield	-169.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.37
1D price change	0%
1M price change	1.92%
1M total return	1.92%
20-day SMA	AUD 0.28
200-day SMA	AUD 0.48
3M price change	-3.64%
3M total return	-3.64%
50-day SMA	AUD 0.29
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 1.49
52-week high date	2025-12-01
52-week low	AUD 0.25
52-week low date	2026-09-30
6M price change	-53.3%
6M total return	-53.3%
All-time high	AUD 1.49
All-time high date	2025-12-01
All-time low	AUD 0.25
All-time low date	2026-07-30
Average true range (ATR)	AUD 0.01
Average volume	54.4K
Beta (1Y)	0.01
Change from 52-week high	-82.21%
Change from 52-week low	6%
Change from all-time high	-82.21%
Change from all-time low	6%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 15,790
High price	AUD 0.27
Low price	AUD 0.26
Monthly RSI	0
Open price	AUD 0.27
Position in 52-week range	100%
Previous close	AUD 0.27
Price vs 150-day SMA	-29.26%
Price vs 20-day SMA	-3.95%
Price vs 200-day SMA	-45.12%
Price vs 50-day SMA	-10.05%
Relative volume	1.11
RSI	43.22
Sharpe ratio	-2.1
Sortino ratio	-2.72
Volume	59.6K
Weekly RSI	34.3
YTD price change	-74.02%
YTD total return	-74.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117.3M
Shares change (QoQ)	151.78%
Shares change (YoY)	169.87%
Shares held by insiders	3.04%
Shares held by institutions	20.04%
Shares outstanding	216.7M

Deeper analysis on ASX/EPI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/EPI report

Is a complete ASX/EPI research report available?

No complete published report is available for asx/EPI (ASX/EPI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/EPI (ASX/EPI)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/EPI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/EPI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/EPI

Frequently asked questions